Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer
Huw, L-Y, O'Brien, C, Pandita, A, Mohan, S, Spoerke, J M, Lu, S, Wang, Y, Hampton, G M, Wilson, T R, Lackner, M R
Published in Oncogenesis (New York, NY) (01.12.2013)
Published in Oncogenesis (New York, NY) (01.12.2013)
Get full text
Journal Article
382 Phase Ib study of oral dual-PI3K/mTOR inhibitor GDC-0980 in combination with capecitabine and mFOLFOX6 + bevacizumab in patients with advanced solid tumors and colorectal cancer
Rosen, L, Goldman, J, Hubbard, J.M, Roos, M, Capdevila, J, Maynes, J, Lin, W, O'Keeffe, B, Lackner, M, Spoerke, J, Ware, J, Arnieri, B, Freas, E, Leong, S
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
A Missense Single-Nucleotide Polymorphism in a Gene Encoding a Protein Tyrosine Phosphatase ( PTPN22) Is Associated with Rheumatoid Arthritis
Begovich, Ann B., Carlton, Victoria E.H., Honigberg, Lee A., Schrodi, Steven J., Chokkalingam, Anand P., Alexander, Heather C., Ardlie, Kristin G., Huang, Qiqing, Smith, Ashley M., Spoerke, Jill M., Conn, Marion T., Chang, Monica, Chang, Sheng-Yung P., Saiki, Randall K., Catanese, Joseph J., Leong, Diane U., Garcia, Veronica E., McAllister, Linda B., Jeffery, Douglas A., Lee, Annette T., Batliwalla, Franak, Remmers, Elaine, Criswell, Lindsey A., Seldin, Michael F., Kastner, Daniel L., Amos, Christopher I., Sninsky, John J., Gregersen, Peter K.
Published in American journal of human genetics (01.08.2004)
Published in American journal of human genetics (01.08.2004)
Get full text
Journal Article
495 The PI3K/mTOR Inhibitor GDC-0980 Demonstrates Target Engagement and Pathway Modulation in Tumor Tissue at Tolerated Doses
Yan, Y, Spoerke, J, Wu, J, Desai, R, Koeppen, H, Hampton, G, Fredrickson, J, Derynck, M, Lauchle, J, Lackner, M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C. elegans
Smardon, A, Spoerke, J M, Stacey, S C, Klein, M E, Mackin, N, Maine, E M
Published in Current biology (24.02.2000)
Published in Current biology (24.02.2000)
Get full text
Journal Article
Trauma induces a hypercoagulable state that is resistant to hypothermia as measured by thrombelastogram
Differding, Jerome A., M.P.H, Underwood, Samantha J., M.S, Van, Philbert Y., M.D, Khaki, Rakan A, Spoerke, Nicholas J., M.D, Schreiber, Martin A., M.D., F.A.C.S
Published in The American journal of surgery (01.05.2011)
Published in The American journal of surgery (01.05.2011)
Get full text
Journal Article
High-throughput isolation of Caenorhabditis elegans deletion mutants
Liu, L X, Spoerke, J M, Mulligan, E L, Chen, J, Reardon, B, Westlund, B, Sun, L, Abel, K, Armstrong, B, Hardiman, G, King, J, McCague, L, Basson, M, Clover, R, Johnson, C D
Published in Genome research (01.09.1999)
Published in Genome research (01.09.1999)
Get full text
Journal Article
The use of lyophilized plasma in a severe multi-injury pig model
Lee, Tim H., Van, Philbert Y., Spoerke, Nicholas J., Hamilton, Gregory J., Cho, S. David, Watson, Kate, Differding, Jerome, Schreiber, Martin A.
Published in Transfusion (Philadelphia, PA) (01.01.2013)
Published in Transfusion (Philadelphia, PA) (01.01.2013)
Get full text
Journal Article
Conference Proceeding
First Place Residents' Competition: trauma induces a hypercoagulable state that is resistant to hypothermia as measured by thrombelastogram
Differding, Jerome A., Underwood, Samantha J., Van, Philbert Y., Khaki, Rakan A., Spoerke, Nicholas J., Schreiber, Martin A.
Published in The American journal of surgery (2011)
Published in The American journal of surgery (2011)
Get full text
Journal Article
Conference Proceeding
Abstract PD6-03: High prevalence and clonal heterogeneity of ESR1 mutations (mt) in circulating tumor DNA (ctDNA) from patients (pts) enrolled in FERGI, a randomized phase II study testing pictilisib (GDC-0941) in combination with fulvestrant (F) in pts that failed a prior aromatase inhibitor (AI)
Spoerke, J, Gendreau, S, Johnston, S, Schmid, P, Krop, I, Qui, J, Derynck, M, Chan, I, Walter, K, Amler, L, Hampton, G, Lackner, M
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P6-05-09: Development of a predictive biomarker gene expression signature for the PIK3CA inhibitor, GDC-0032, in breast cancer cells
Savage, H, O'Brien, C, Spoerke, J, Huw, L, Wallin, J, Friedman, L, Lackner, MR, Wilson, TR
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
1230PDPHASE 1B STUDY OF ORAL DUAL-PI3K/MTOR INHIBITOR GDC-0980 IN COMBINATION WITH CARBOPLATIN (CARBO)/PACLITAXEL (PAC) ± BEVACIZUMAB (BEV) AND CISPLATIN (CIS)/PEMETREXED (PEM) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS AND NSCLC
Calvo, E., Boni, V., Heist, R.S., Matulonis, U., Janne, P.A., Hamid, O., Holgado, E., Ordoñez, J.M., Nunez, J., Ugrenovic, M., Lin, W., O'keeffe, B., Lackner, M.R., Spoerke, J., Ware, J., Pinder-Schenck, M.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Phase 1B Study of Oral Dual-Pi3K/Mtor Inhibitor Gdc-0980 in Combination with Carboplatin (Carbo)/Paclitaxel (Pac) ± Bevacizumab (Bev) and Cisplatin (Cis)/Pemetrexed (Pem) in Patients (Pts) with Advanced Solid Tumors and Nsclc
Calvo, E., Boni, V., Heist, R.S., Matulonis, U., Janne, P.A., Hamid, O., Holgado, E., Ordoñez, J.M., Nunez, J., Ugrenovic, M., Lin, W., O'keeffe, B., Lackner, M.R., Spoerke, J., Ware, J., Pinder-Schenck, M.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Abstract P5-11-01: Phamacodynamic and circulating tumor DNA evaluation in a phase I study of GDC-0927, a selective estrogen receptor antagonist/ degrader (SERD)
Spoerke, JM, Daemen, A, Chang, C-W, Giltnane, J, Metcalfe, C, Dickler, MN, Bardia, A, Perez Fidalgo, JA, Mayer, IA, Boni, V, Winer, EP, Hamilton, EP, Bellet, M, Urruticoechea, A, Gonzalez Martin, A, Cortes, J, Martin, M, Gates, M, Cheeti, S, Fredrickson, J, Wang, X, Friedman, LS, Liu, L, Li, R, Chan, IT, Mueller, L, Milan, S, Lauchle, J, Humke, EW, Lackner, MR
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P6-07-08: The complete spectrum of ESR1 mutations from 7590 breast cancer tumor samples
Spoerke, JM, Schleifman, E, Clark, TA, Young, G, Nahas, M, Kennedy, M, Young, L, Chmielecki, J, Otto, GA, Lipson, D, Wilson, TR, Gendreau, S, Lackner, MR
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Lyophilized plasma reconstituted with ascorbic acid suppresses inflammation and oxidative DNA damage
Van, Philbert Y, Hamilton, Gregory J, Kremenevskiy, Igor V, Sambasivan, Chitra, Spoerke, Nicholas J, Differding, Jerome A, Watters, Jennifer M, Schreiber, Martin A
Published in The journal of trauma (01.07.2011)
Published in The journal of trauma (01.07.2011)
Get more information
Journal Article